Articles published by Sensei Biotherapeutics, Inc.

Sensei Biotherapeutics Announces Name Change to Faeth Therapeutics, Focused on Advancing PIKTOR, an Oral Therapy Targeting One of the Most Frequently Altered Pathways in Cancer

June 15, 2026

From Sensei Biotherapeutics, Inc.

Via Business Wire

Tickers SNSE

Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

June 04, 2026

From Sensei Biotherapeutics, Inc.

Via Business Wire

Tickers SNSE

Sensei Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

May 15, 2026

From Sensei Biotherapeutics, Inc.

Via Business Wire

Tickers SNSE

Sensei Biotherapeutics Doses First Patient in Phase 1b/2 Trial of PIKTOR in HR+/HER2- Advanced Breast Cancer

May 05, 2026

From Sensei Biotherapeutics, Inc.

Via Business Wire

Tickers SNSE

Sensei Biotherapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference

April 09, 2026

From Sensei Biotherapeutics, Inc.

Via Business Wire

Tickers SNSE

Sensei Biotherapeutics Reports Full Year 2025 Financial Results and Provides Corporate Update

March 30, 2026

From Sensei Biotherapeutics, Inc.

Via Business Wire

Tickers SNSE

Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

March 17, 2026

From Sensei Biotherapeutics, Inc.

Via Business Wire

Tickers SNSE

Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 25, 2026

From Sensei Biotherapeutics, Inc.

Via Business Wire

Tickers SNSE

Sensei Biotherapeutics Announces Acquisition of Faeth Therapeutics and $200 Million Concurrent Private Placement

February 18, 2026

From Sensei Biotherapeutics, Inc.

Via Business Wire

Tickers SNSE

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.